PLACIDI, FABIO
 Distribuzione geografica
Continente #
NA - Nord America 40.761
AS - Asia 6.653
EU - Europa 4.447
SA - Sud America 764
AF - Africa 111
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 12
Totale 52.765
Nazione #
US - Stati Uniti d'America 40.545
SG - Singapore 3.832
IT - Italia 1.056
CN - Cina 961
BR - Brasile 636
RU - Federazione Russa 577
DE - Germania 519
UA - Ucraina 498
HK - Hong Kong 448
IE - Irlanda 443
VN - Vietnam 427
GB - Regno Unito 296
BD - Bangladesh 293
FR - Francia 276
FI - Finlandia 201
KR - Corea 201
SE - Svezia 161
JP - Giappone 155
CA - Canada 132
PL - Polonia 113
NL - Olanda 94
IN - India 72
AR - Argentina 53
ID - Indonesia 50
ES - Italia 41
MX - Messico 40
ZA - Sudafrica 36
AT - Austria 35
IQ - Iraq 32
CZ - Repubblica Ceca 29
TR - Turchia 25
EG - Egitto 23
BE - Belgio 22
PH - Filippine 17
AE - Emirati Arabi Uniti 15
EC - Ecuador 15
AU - Australia 13
CL - Cile 13
IL - Israele 13
JM - Giamaica 13
MY - Malesia 13
MA - Marocco 12
PK - Pakistan 12
CO - Colombia 11
GR - Grecia 11
PE - Perù 11
TN - Tunisia 11
VE - Venezuela 11
DK - Danimarca 10
EU - Europa 10
KG - Kirghizistan 10
LT - Lituania 10
PY - Paraguay 10
UZ - Uzbekistan 10
CH - Svizzera 9
NP - Nepal 9
RO - Romania 9
SA - Arabia Saudita 9
PT - Portogallo 8
ET - Etiopia 7
KE - Kenya 7
KZ - Kazakistan 7
BG - Bulgaria 6
DZ - Algeria 6
TH - Thailandia 6
QA - Qatar 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
AZ - Azerbaigian 4
BA - Bosnia-Erzegovina 4
CR - Costa Rica 4
HN - Honduras 4
HU - Ungheria 4
JO - Giordania 4
NI - Nicaragua 4
AL - Albania 3
AM - Armenia 3
BO - Bolivia 3
GE - Georgia 3
LB - Libano 3
NZ - Nuova Zelanda 3
SI - Slovenia 3
SN - Senegal 3
SV - El Salvador 3
BB - Barbados 2
BS - Bahamas 2
HR - Croazia 2
IR - Iran 2
LK - Sri Lanka 2
PA - Panama 2
PS - Palestinian Territory 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AO - Angola 1
BW - Botswana 1
CI - Costa d'Avorio 1
CY - Cipro 1
DM - Dominica 1
GT - Guatemala 1
Totale 52.750
Città #
Woodbridge 10.620
Wilmington 9.976
Houston 8.779
Fairfield 1.361
Singapore 1.191
Ashburn 1.075
Ann Arbor 803
Chandler 656
San Jose 646
Seattle 579
Cambridge 474
Hong Kong 435
Jacksonville 411
Beijing 408
Dublin 406
Medford 307
Council Bluffs 298
New York 280
Santa Clara 225
Rome 222
Los Angeles 202
Dearborn 174
The Dalles 163
Lawrence 145
Ho Chi Minh City 137
Tokyo 122
Moscow 108
Milan 105
Buffalo 103
Lauterbourg 102
Helsinki 95
San Diego 92
Hanoi 91
Dallas 90
Kraków 82
Menlo Park 82
Colorado Springs 79
São Paulo 76
Boardman 60
Zhengzhou 57
Orem 53
Monte Vista 51
London 49
Munich 48
Norwalk 45
Toronto 45
Mülheim 41
North Bergen 36
Denver 35
Chicago 33
Atlanta 32
Montreal 32
Phoenix 32
Shanghai 31
Brooklyn 30
Naples 30
Redwood City 30
Nuremberg 29
Columbus 28
Jakarta 28
Memphis 28
Stockholm 28
San Francisco 26
Verona 26
Palo Alto 25
Haiphong 24
Amsterdam 23
Frankfurt am Main 23
Manchester 23
Miano 23
Rio de Janeiro 23
Warsaw 23
Brno 22
Brussels 22
Johannesburg 22
Guangzhou 21
Belo Horizonte 20
Da Nang 20
Washington 20
Boston 19
Mountain View 18
Vienna 18
Chennai 17
Florence 17
Miami 17
Daejeon 16
Istanbul 16
Seoul 16
Salt Lake City 15
University Park 15
Cairo 14
Redondo Beach 14
Biên Hòa 13
Falls Church 13
Kilburn 13
Mexico City 13
Bologna 12
Hefei 12
Pune 12
Hangzhou 11
Totale 42.808
Nome #
Symptomatic nonconvulsive status epilepticus erroneously suggestive of sporadic Creutzfeldt-Jakob disease 627
Dynamic susceptibility contrast (DSC) MRI and interictal epileptiform activity in cryptogenic partial epilepsy 590
Increased cortical excitability after selective REM sleep deprivation in healthy humans: a transcranial magnetic stimulation study 589
Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2 586
Spastic paraplegia, epilepsy, and mental retardation in several members of a family: a novel genetic disorder 564
Paucisymptomatic Marchiafava-Bignami disease with relevant diffusion-weighted MRI lesions 558
Coma, alterazioni della coscienza e sonno 535
Sleep episodes and daytime somnolence as result of individual susceptibility to different dopaminergic drugs in a PD patient: a polysomnographic study 535
Unexpected total recovery in a patient with post-anoxic complete alpha coma predicted by recording of cortical SEPs 519
Development of collateral veins as a favorable prognostic factor for complete recovery in cerebral venous thrombosis due to Tribulus terrestris 519
Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy. 515
L-dopa-induced excessive daytime sleepiness in PD: a placebo-controlled case with MSLT assessment. 512
Chronic dopaminergic treatment in restless legs syndrome: Does it affect the autonomic nervous system? 508
Pregabalin as add-on therapy induces REM sleep enhancement in partial epilepsy: A polysomnographic study 505
Baroreflex Buffering of Sympathetic Activation during Sleep: Evidence from Autonomic Assessment of Sleep Macroarchitecture and Microarchitecture 501
Predicting seizures in untreated temporal lobe epilepsy using point-process nonlinear models of heartbeat dynamics 485
Cognitive and psychiatric effects of topiramate monotherapy in migraine treatment: an open study. 484
Bilateral frontal polymicrogyria and epilepsy in a patient with Turner mosaicism: a case report 482
Effective treatment of narcolepsy-cataplexy with duloxetine: a report of three cases. 480
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population: further data and comments 480
Cerebral hemodynamic changes in sleep apnea syndrome and effect of continuous positive airway pressure treatment 478
Continuous positive airway pressure treatment increases serum vitamin D levels in male patients with obstructive sleep apnea 477
Bilateral thalamic stroke due to nasal ephedrine and naphazoline use 474
Effects of epilepsy treatment on sleep architecture and daytime sleepiness: an evidence-based review of objective sleep metrics 473
Multicenter case-control study on restless legs syndrome in multiple sclerosis: The REMS Study 470
Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease 464
Increasing cortical excitability: A possible explanation for the proconvulsant role of sleep deprivation 463
Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease 463
Topiramate: effect on EEG interictal abnormalities and background activity in patients affected by focal epilepsy. 462
Unilateral spatial neglect and alien limb phenomenon may be early features of Creutzfeldt-Jakob disease 456
Cerebrovascular reactivity and subcortical infarctions 455
Sleep disorders in myotonic dystrophy type 2: a controlled polysomnographic study and self-reported questionnaires 454
Temporal lobe epileptic activity mimicking dementia: a case report 453
Optic Nerve dysfunction in obstructive sleep apnea: An electrophysiological study 451
Changes in nocturnal sleep and day time somnolence after CBZ administration [MODIFICAZIONI DEL SONNO NOTTURNO E DELLA SONNOLENZA DIURNA DOPO SOMMINISTRAZIONE DI CARBAMAZEPINA] 449
Nocturnal sleep and daytime somnolence in untreated patients with temporal lobe epilepsy: changes after treatment with controlled-release carbamazepine 445
Ketotic hyperglycemia and epilepsia partialis continua 445
Changes of the EEG paroxysmal pattern during felbamate therapy in Lennox-Gastaut syndrome: a case report. 445
Restless legs syndrome and poliomyelitis: New evidences of an old observation? 443
Panic attacks as ictal manifestation of a meningioma of the left anterior clinoid [Attacchi di panico come manifestazioni critiche di un meningioma della clinoide anteriore sinistra] 441
Estrogen deficiency hampers the beneficial effect of continuous positive airway pressure therapy on serum vitamin D concentrations in postmenopausal women affected by obstructive sleep apnea 441
Pure ictal sensory seizures may represent a clinical manifestation of PLEDs 440
CSF Biomarkers for Early Diagnosis of Synucleinopathies: Focus on Idiopathic RBD 438
Fronto-central monomorphic theta activity as EEG pattern of ictal psychosis 436
Effect of cabergoline added to levodopa treatment on sleep-wake cycle in idiopathic Parkinson's disease: an open label 24-hour polysomnographic study 436
Gabapentin as add-on therapy in focal epilepsy: a computerized EEG study 435
Panic disorder or epilepsy? A case report 434
Pedunculopontine nucleus stimulation influences REM sleep in Parkinson's disease 433
Effects of zonisamide as add-on therapy on sleep-wake cycle in focal epilepsy: a polysomnographic study 433
Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. 433
Cerebrospinal-fluid orexin levels and daytime somnolence in frontotemporal dementia 432
Oxcarbazepine in Nocturnal Frontal-Lobe Epilepsy: A Further Interesting Report 431
Effective treatment of nocturnal frontal lobe epilepsy with lacosamide: a report of two cases 430
Physical activity contradictorily affects bone mineral density in obstructive sleep apnea patients at different ages 430
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population 427
Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time 427
Sleep disorders in spinal and bulbar muscular atrophy (Kennedy's disease): a controlled polysomnographic and self-reported questionnaires study 422
Sleep-wake cycle and effects of cabergoline monotherapy in de novo Parkinson's disease patients - An ambulatory polysomnographic study 420
A 23 years follow-up study identifies GLUT1 deficiency syndrome initially diagnosed as complicated hereditary spastic paraplegia 420
null 419
Rotigotine effect on sleep in a de novo Parkinson's Disease patient affected by periodic limb movement disorder 418
Gabapentin-induced modulation of interictal epileptiform activity related to different vigilance levels 414
Spasticity as an ictal pattern due to excitotoxic upper motor neuron damage 414
Sleep in healthy elderly subjects: A 24-hour ambulatory polysomnographic study 412
Impairment of daytime cerebrovascular reactivity in patients with obstructive sleep apnoea syndrome 408
Topiramate-induced restless legs syndrome: A report of two cases [3] 400
CSF beta-amyloid levels are altered in narcolepsy: a link with the inflammatory hypothesis? 399
Is autonomic nervous system involved in restless legs syndrome during wakefulness? 399
Restless legs syndrome and post polio syndrome: a case-control study 398
Sleep abnormalities in mentally retarded autistic subjects: Down's syndrome with mental retardation and normal subjects 397
Is autonomic nervous system involved in restless legs syndrome during wakefulness? 396
May CSF beta-amyloid and tau proteins levels be influenced by long treatment duration and stable medication in narcolepsy? 395
Rotigotine may improve sleep architecture in Parkinson's disease: a double-blind, randomized, placebo-controlled polysomnographic study. 394
Multiple sleep latency test may be not sensitive in obstructive sleep apnea with comorbid narcolepsy revealed by low cerebrospinal fluid orexin levels 393
Nocturnal frontal lobe epilepsy with paroxysmal arousals due to CHRNA2 loss of function 393
Effect of antiepileptic drugs on sleep 390
Lacosamide as add-on treatment of focal symptomatic epilepsy in a patient with alcoholic liver cirrhosis 390
Does continuous positive airway pressure treatment affect autonomic nervous system in patients with severe obstructive sleep apnea? 390
Bilateral hemispheric activation in the early recovery of motor function after stroke 388
Electroencephalography and dementia: a literature review and future perspectives 388
Case report: subependymal diffuse heterotopia. Clinical, EEG, and neuroimaging findings 383
Cognitive profile and brain morphological changes in obstructive sleep apnea 382
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study 382
Multiple idiosyncratic adverse effects of antiepileptic drugs in a patient with partial trisomy of chromosome 9 and epilepsy [Reazioni idiosincrasiche multiple a farmaci antiepilettici in una paziente con trisomia parziale del cromosoma 9 ed epilessia] 381
Folic acid supplements during pregnancy in specific clinical settings: What dowe know about epilepsy? 374
Daytime autonomic activity in idiopathic rapid eye movement sleep behavior disorder: a preliminary study 373
Ictal aphasia as manifestation of partial status epilepticus in a long-lasting misdiagnosed symptomatic epilepsy: An emblematic case 371
Effects of adjunctive perampanel on sleep quality, daytime somnolence and cognition in refractory focal epilepsy: Further data 369
MicroRNA expression is dysregulated in narcolepsy: A new evidence? 367
Sleep disorders in adult-onset myotonic dystrophy type 1: a controlled polysomnographic study 359
Non-motor functions in parkinsonian patients implanted in the pedunculopontine nucleus: focus on sleep and cognitive domains. 358
Obstructive sleep apnoea and bone health 358
Sleep-wake cycle in the Kennedy's disease: a controlled polysomnographic study and self-reported questionnaires 350
Pedunculopontine nucleus stimulation influences REM sleep in Parkinson's disease 350
Circadian variation of fatigue in paralytic poliomyelitis and postpolio syndrome: just fatigue or masked restless legs syndrome? 330
Evaluation of patients with focal epilepsy in the intercritical phase with perfusion mr imaging and eeg 324
Sleep apnoeas may represent a reversible risk factor for amyloid-β pathology 324
Continuous positive airway pressure treatment may improve optic nerve function in obstructive sleep apnea: An electrophysiological study 322
Clinical case report: multiple idiosyncratic adverse effects of antiepileptic drugs in trisomy 9p 311
Levetiracetam, lamotrigine and carbamazepine: which monotherapy during pregnancy? 301
Totale 43.397
Categoria #
all - tutte 130.995
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.995


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.530 77 97 71 33 48 120 113 45 86 131 71 638
2022/20231.877 226 131 55 230 175 427 161 111 163 38 104 56
2023/2024763 104 23 35 40 66 230 31 57 13 24 15 125
2024/20255.189 132 734 396 219 79 449 157 173 342 243 1.307 958
2025/20267.428 473 273 763 616 546 267 931 787 747 685 905 435
2026/2027649 649 0 0 0 0 0 0 0 0 0 0 0
Totale 53.335